Nucleo uses Nebius GPU cloud credits awarded through the 2026 AI Discovery Awards for medical imaging model development. The company reports training across larger and more varied CT and MRI cohorts, covering different scanners, reconstruction kernels and acquisition protocols. This work targets segmentation and detection that generalize beyond their original training data.
Nucleo’s oncology software supports body composition assessment, lesion measurement and lesion classification. Its August 2026 update also describes expanded lung nodule characterization, including volumetric measurements and segmentation overlays. The company identifies that module as adjunctive and for research use only.
What's new in NucleoPublished 4 Aug 2026 · Inside Nucleo / Substack · Web pageNucleo reports using awarded Nebius GPU cloud credits for model development and training across varied CT and MRI cohorts.
Nebius announces 2026 AI Discovery Award winners
Published 2 Jul 2026 · Nebius · Web page
Nebius names Nucleo Research as the first-place Medical Imaging winner in its 2026 AI Discovery Awards.
Nebius announces 2026 AI Discovery Award winnersPublished 2 Jul 2026 · Nebius · Web pageNebius names Nucleo Research as the first-place Medical Imaging winner in its 2026 AI Discovery Awards.
Nebius names Nucleo among award winners
Listed 20 Oct 2026 · LinkedIn · Web page
Nebius’s awards post names Nucleo as the first-place Medical Imaging winner.
Nebius names Nucleo among award winnersListed 20 Oct 2026 · LinkedIn · Web pageNebius’s awards post names Nucleo as the first-place Medical Imaging winner.
Nucleo, operated by Nucleo Research, Inc., develops AI software that automates CT scan analysis for oncology workflows. Its platform helps oncologists, radiologists and researchers quantify fat and muscle, assess sarcopenia, measure tumor lesions and classify target versus non-target lesions using RECIST criteria. Its lung-nodule module produces characterization reports with detection confidence, classification, volumetric measurements and segmentation overlays; this module is designated for research use only. Nucleo also provides organ segmentation and body-composition analysis from the same scan.
Documented financing · private company
AmountUndisclosedNorthwestern Medicine Ventures accelerator investment; stage unspecified
Nucleo expanded its lung-nodule module from detection to structured reports covering malignancy classification, anatomical location, volumetric measurements and tissue characteristics. The module is available for research use only.
Nucleo develops software that automates CT scan analysis for oncology care. · Health
How they use Nebius AI Cloud
Nucleo uses Nebius GPU cloud credits awarded through the 2026 AI Discovery Awards for medical imaging model development. The company reports training across larger and more varied CT and MRI cohorts, covering different scanners, reconstruction kernels and acquisition protocols. This work targets segmentation and detection that generalize beyond their original training data.
Nucleo’s oncology software supports body composition assessment, lesion measurement and lesion classification. Its August 2026 update also describes expanded lung nodule characterization, including volumetric measurements and segmentation overlays. The company identifies that module as adjunctive and for research use only.
What's new in NucleoPublished 4 Aug 2026 · Inside Nucleo / Substack · Web pageNucleo reports using awarded Nebius GPU cloud credits for model development and training across varied CT and MRI cohorts.
Nebius announces 2026 AI Discovery Award winners
Published 2 Jul 2026 · Nebius · Web page
Nebius names Nucleo Research as the first-place Medical Imaging winner in its 2026 AI Discovery Awards.
Nebius announces 2026 AI Discovery Award winnersPublished 2 Jul 2026 · Nebius · Web pageNebius names Nucleo Research as the first-place Medical Imaging winner in its 2026 AI Discovery Awards.
Nebius names Nucleo among award winners
Listed 20 Oct 2026 · LinkedIn · Web page
Nebius’s awards post names Nucleo as the first-place Medical Imaging winner.
Nebius names Nucleo among award winnersListed 20 Oct 2026 · LinkedIn · Web pageNebius’s awards post names Nucleo as the first-place Medical Imaging winner.
Nucleo, operated by Nucleo Research, Inc., develops AI software that automates CT scan analysis for oncology workflows. Its platform helps oncologists, radiologists and researchers quantify fat and muscle, assess sarcopenia, measure tumor lesions and classify target versus non-target lesions using RECIST criteria. Its lung-nodule module produces characterization reports with detection confidence, classification, volumetric measurements and segmentation overlays; this module is designated for research use only. Nucleo also provides organ segmentation and body-composition analysis from the same scan.
Documented financing · private company
AmountUndisclosedNorthwestern Medicine Ventures accelerator investment; stage unspecified
Nucleo expanded its lung-nodule module from detection to structured reports covering malignancy classification, anatomical location, volumetric measurements and tissue characteristics. The module is available for research use only.
